MARC Record from Library of Congress

LEADER: 01766nam a22003735a 4500
001 2009284679
003 DLC
005 20090808122713.0
008 090715s2009 dcua b 000 0 eng d
010 $a 2009284679
020 $a0309128676
020 $a9780309128674
035 $a(OCoLC)ocn310392638
040 $aYDXCP$cYDXCP$dNRZ$dNTD$dBTCTA$dCDX$dIXA$dEEM$dDLC
042 $alccopycat
082 04 $a610.724$222
050 00 $aR853.C55$bM85 2009
245 00 $aMulti-center phase III clinical trials and NCI cooperative groups :$bworkshop summary /$cMargie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies.
260 $aWashington, D.C. :$bNational Academies Press,$c2009
300 $axii, 121 p. :$bill. ;$c23 cm.
504 $aIncludes bibliographical references (p. 97-101).
505 0 $aIntroduction -- Organization of the NCI clinical trials system -- Lessons from non-cooperative group multi-center clinical trials -- Barriers to patient recruitment and physician participation -- Data collection standards and monitoring -- Costs of cooperative group clinical trials -- Summary and wrap-up.
530 $aAlso available online.
650 0 $aCancer$xTreatment$zUnited States.
650 0 $aClinical trials.
610 22 $aNational Cancer Institute (U.S.).
650 12 $aClinical Trials, Phase III as Topic$zUnited States.
650 12 $aMulticenter Studies as Topic$zUnited States.
700 1 $aPatlak, Margie.
700 1 $aNass, Sharyl J.
700 1 $aMicheel, Christine.
710 2 $aNational Cancer Policy Forum (U.S.).
710 2 $aInstitute of Medicine (U.S.)
856 41 $uhttp://search.nap.edu/nap-cgi/de.cgi?term=0309128676$zView online options